We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.22B
AUM Growth
+$186M
Cap. Flow
+$231M
Cap. Flow %
10.43%
Top 10 Hldgs %
42.94%
Holding
2,313
New
704
Increased
422
Reduced
406
Closed
646

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$29.3M
2
CPE
Callon Petroleum Company
CPE
+$20.4M
3
MDSO
Medidata Solutions, Inc.
MDSO
+$15M
4
PSDO
Presidio, Inc. Common Stock
PSDO
+$13.9M
5
MSFT icon
Microsoft
MSFT
+$7.53M

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$41.9M
2
RHT
Red Hat Inc
RHT
+$37.8M
3
ARRY
Array Biopharma Inc
ARRY
+$26.1M
4
FDC
First Data Corporation
FDC
+$25.5M
5
BID
Sotheby's
BID
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 6.33%
2 Healthcare 5.48%
3 Consumer Discretionary 4.35%
4 Industrials 3%
5 Real Estate 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BERY
1576
DELISTED
Berry Global Group, Inc.
BERY
$4K ﹤0.01%
+118
New +$4.82K
SCTL
1577
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$4K ﹤0.01%
376
– –
CHNG
1578
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$4K ﹤0.01%
+335
New +$4.6K
CLCT
1579
DELISTED
Collectors Universe
CLCT
$4K ﹤0.01%
129
-3,859
-97% -$93.9K
BKJ
1580
DELISTED
Bancorp of New Jersey, Inc.
BKJ
$4K ﹤0.01%
+208
New +$3.12K
BHVN
1581
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4K ﹤0.01%
100
-2,800
-97% -$118K
BHVN
1582
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4K ﹤0.01%
+100
New +$4.22K
AIRG icon
1583
Airgain
AIRG
$72.4M
$3K ﹤0.01%
244
-6,379
-96% -$79.4K
AMRN
1584
CALL
Amarin Corp
AMRN
$303M
$3K ﹤0.01%
10
-2,030
-100% -$709K
CEVA icon
1585
CEVA Inc
CEVA
$1.08B
$3K ﹤0.01%
100
-1,222
-92% -$35.6K
GME icon
1586
PUT
GameStop
GME
$8.6B
$3K ﹤0.01%
2,000
-400
-17% -$432
HTLD icon
1587
Heartland Express
HTLD
$956M
$3K ﹤0.01%
+141
New +$2.83K
IQ icon
1588
PUT
iQIYI
IQ
$1.28B
$3K ﹤0.01%
+200
New +$3.67K
LGL icon
1589
LGL Group
LGL
$46.5M
$3K ﹤0.01%
+796
New +$2.73K
SGA icon
1590
Saga Communications
SGA
$63.9M
$3K ﹤0.01%
+100
New +$2.99K
SGMO
1591
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3K ﹤0.01%
324
-39
-11% -$438
TGTX icon
1592
CALL
TG Therapeutics
TGTX
$7.62B
$3K ﹤0.01%
500
-400
-44% -$2.79K
TR icon
1593
Tootsie Roll Industries
TR
$2.98B
$3K ﹤0.01%
+100
New +$3.02K
WST icon
1594
West Pharmaceutical
WST
$24.9B
$3K ﹤0.01%
+22
New +$3.03K
XRX icon
1595
CALL
Xerox
XRX
$425M
$3K ﹤0.01%
100
– –
HARP
1596
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$3K ﹤0.01%
+20
New +$2.81K
BLU
1597
DELISTED
BELLUS Health Inc.
BLU
$3K ﹤0.01%
+435
New +$3.07K
ASAP
1598
PUT
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$3K ﹤0.01%
+115
New +$7.38K
CLVS
1599
DELISTED
Clovis Oncology, Inc.
CLVS
$3K ﹤0.01%
702
-6
-0.8% -$49
FBM
1600
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$3K ﹤0.01%
+200
New +$3.47K
62 63
64
65 66

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Prelude Capital Management held 2,313 positions worth $2.22B, up 9.1% from $2.03B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Prelude Capital Management deployed $231M of net new capital in Q3 2019, opening 704 new positions and adding to 422 existing holdings. Its largest new stake was Callon Petroleum Company: 418,579 shares worth $18.2M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stewart Information Services, an estimated $7.45M trimmed.

  • Prelude Capital Management's largest Q3 2019 buy was Callon Petroleum Company: 418,579 shares worth $18.2M.
  • Prelude Capital Management added most to Altaba Inc in Q3 2019, an estimated $29.3M increase.
  • Prelude Capital Management's biggest Q3 2019 reduction was Stewart Information Services, cutting an estimated $7.45M.
  • Prelude Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $41.9M.
  • Prelude Capital Management's ten largest holdings make up 43% of its $2.22B portfolio in Q3 2019.
  • Prelude Capital Management opened 704 new positions and closed 646 in Q3 2019.
  • Prelude Capital Management's portfolio value rose 9.1% quarter-over-quarter to $2.22B.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.